CRISPR-Cas9-mediated reactivation of the uricase pseudogene in human cells prevents acute hyperuricemia
The utility of CRISPR-Cas9 to repair or reverse diseased states that arise from recent genetic mutations in the human genome is now widely appreciated. The use of CRISPR to "design" the outcomes of biology is challenged by both specialized ethicists and the general public. Less of a focus,...
Saved in:
Main Authors: | Lais de Lima Balico (Author), Eric A. Gaucher (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CRISPR-Cas9 mediated phage therapy as an alternative to antibiotics
by: Fikre Birhanu Balcha, et al.
Published: (2023) -
CRISPR/Cas9-mediated genome editing in nonhuman primates
by: Yu Kang, et al.
Published: (2019) -
RNA-Guided CRISPR-Cas9 System-Mediated Engineering of Acute Myeloid Leukemia Mutations
by: Oliver Brabetz, et al.
Published: (2017) -
Off-target Effects in CRISPR/Cas9-mediated Genome Engineering
by: Xiao-Hui Zhang, et al.
Published: (2015) -
CRISPR/Cas9-Mediated Customizing Strategies for Adoptive T-Cell Therapy
by: Hyeseon Park, et al.
Published: (2024)